Using lumbar drainage to treat intraventricular hemorrhage
Official title: Lumbar Drainage of Intraventricular Hemorrhage The DRAIN IVH Randomized Controlled Trial
Run by University Hospital Heidelberg · NCT06510842 · Data updated 2026-11-12
This study is testing if using lumbar drainage early on can help patients with intraventricular hemorrhage recover better and reduce the need for permanent shunts.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 354 (estimated) |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 12 sites (Heidelberg, Baden-Wurttemberg and 11 other locations) |
| Status | Recruiting |
| Started | January 16, 2025 |
| Main results expected | January 2029 |
| Study ends | July 2029 |
| Registry record updated | January 28, 2026 |
| Trial ID | NCT06510842 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with intracerebral hemorrhage and intraventricular hemorrhage requiring EVD placement within 72 hours of symptom onset.
✕Probably not a fit
Patients with a poor premorbid mRS score, those who are pregnant, or individuals with a life expectancy of less than six months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of early lumbar drainage in patients with intraventricular hemorrhage (IVH) who require external ventricular drainage (EVD) due to acute hydrocephalus. The study hypothesizes that adding lumbar drainage will improve functional outcomes and reduce the need for permanent ventriculoperitoneal shunts by facilitating the removal of blood that causes inflammation in the subarachnoid space. It is a multi-center randomized trial conducted at several prominent medical institutions in Germany.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery and reduced long-term complications for patients suffering from intraventricular hemorrhage.
How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, indicating that this may be a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ICH with IVH (with hemorrhage in the 3rd and/or 4rth ventricle) with the need for EVD placement due to acute hydrocephalus * Age ≥ 18 y * Lumbar drain can be inserted within 72 h after symptom onset or patient last seen well Exclusion Criteria: * Premorbid mRS score \> 2 * Pregnancy * Life expectancy \<6 months * Patient/family/caregiver unwilling or unlikely to opt for at least two weeks of aggressive therapy prior to consideration of transition to comfort measures/discontinuation of life support measures. * Treating physicians deeming the prognosis as so grave that an aggressive therapy is not warranted. * Other clear contraindication for treatment with a lumbar drain
Where it's running
-
Department of Neurology, University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, Germany Recruiting -
LMU München
München, Bavaria, Germany Recruiting -
Augsburg University Hospital
Augsburg, Germany Recruiting -
Düsseldorf Universitiy Hospital
Düsseldorf, Germany Recruiting -
Augsburg University Hospital Department of Neurosurgery
Heidelberg, Germany Recruiting -
Heidelberg University Hospital Department of Neurosurgery
Heidelberg, Germany Recruiting
Show 6 more locations
-
Mannheim University Hospital
Mannheim, Germany Recruiting -
Osnabrück Clinic
Osnabrück, Germany Recruiting -
Charite Universitätsmedizin Berlin
Berlin, Germany Not yet recruiting -
Frankfurt University Hospital
Frankfurt, Germany Not yet recruiting -
Goettingen University Hospital
Göttingen, Germany Not yet recruiting -
Mainz University Hospital
Mainz, Germany Not yet recruiting
Study contacts
- Principal investigator: Silvia Schönenberger, MD — Heidelberg University Hospital, Department of Neurology
- Study coordinator: Silvia Schönenberger, MD
- Email: silvia.schoenenberger@med.uni-heidelberg.de
- Phone: 0049/6221/567504
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Looking at tiny particles in cord blood of babies born before 28 weeks
The team will test whether extracellular vesicles in umbilical cord blood can help predict serious complications in babies born before 28 weeks of pregnancy.
-
AI-guided robotic minimally invasive neurosurgery for intracerebral hemorrhage (RAINBOW-ICH)
This trial will test whether AI-assisted, robotic-guided minimally invasive surgery helps adults with spontaneous intracerebral hemorrhage (including basal ganglia, intraventricular, and brainstem types) recover better than conventional care.
-
Using rhTNK-tPA to treat intraventricular hemorrhage
This study is testing a new treatment using rhTNK-tPA for people with bleeding in the brain to see if it can help them recover better and improve their chances of survival.
-
Predicting blockages in external ventricular drains for ICU patients
This study is trying to find out which ICU patients with external ventricular drains are at higher risk for blockages after bleeding in the brain, to help improve their care.
-
Care bundle to improve recovery after intracerebral haemorrhage
This trial will try a structured treatment package—rapid reversal of blood thinners when needed, early intensive blood pressure lowering, and treatment of fever and high blood sugar—to see if it improves 3‑month outcomes for adults with spontaneous intracerebral haemorrhage who arrive within 24 hours of symptom onset.
-
Optimizing oxygen levels for premature infants during resuscitation
This study is testing which oxygen level is best for helping premature babies during resuscitation at birth to improve their chances of survival and long-term health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.